MAPT and Alzheimer disease: The LSPR, immune-based chip was able to detect tau protein to a lower limit of 10 pg/mL, suggesting it would be useful for clinical detection since the cutoff value of tau protein in the cerebral spinal fluid (CSF) for AD patient is 195 pg/mL [46].